Neuroprotective Effect of Natural Products Against Alzheimer’s Disease
Tóm tắt
Từ khóa
Tài liệu tham khảo
Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the global burden of Alzheimer’s disease. Alzheimers Dementia 3:186–191
Walt G (2004) WHO’s World Health Report 2003—shaping the future depends on strengthening health systems. Br Med J 328:6–6
Liu GJ, Huang WD, Moir RD, Vanderburg CR, Lai B, Peng ZC, Tanzi RE, Rogers JT, Huang XD (2006) Metal exposure and Alzheimer’s pathogenesis. J Struct Biol 155:45–51
Williams P, Sorribas A, Howes MJR (2011) Natural products as a source of Alzheimer’s drug leads. Nat Product Rep 28:48–77
Joseph JA, Shukitt-Hale B, Denisova NA, Bielinski D, Martin A, McEwen JJ, Bickford PC (1999) Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J Neurosci 19:8114–8121
Youdim KA, Shukitt-Hale B, Martin A, Wang H, Denisova N, Bickford PC, Joseph JA (2000) Short-term dietary supplementation of blueberry polyphenolics: beneficial effects on aging brain performance and peripheral tissue function. Nutr Neurosci 3:383–397
Casadesus G, Shukitt-Hale B, Stellwagen HM, Zhu XW, Lee HG, Smith MA, Joseph JA (2004) Modulation of hippocampal plasticity and cognitive behavior by short-term blueberry supplementation in aged rats. Nutr Neurosci 7:309–316
Krikorian R, Shidler MD, Nash TA, Kalt W, Vinqvist-Tymchuk MR, Shukitt-Hale B, Joseph JA (2010) Blueberry supplementation improves memory in older adults. J Agric Food Chem 58:3996–4000
McDonald RJ, White NM (1994) Parallel information processing in the water maze: evidence for independent memory systems involving dorsal striatum and hippocampus. Behav Neural Biol 61:260–270
Shukitt-Hale B, Carey AN, Jenkins D, Rabin BM, Joseph JA (2007) Beneficial effects of fruit extracts on neuronal function and behavior in a rodent model of accelerated aging. Neurobiol Aging 28:1187–1194
Andres-Lacueva C, Shukitt-Hale B, Galli RL, Jauregui O, Lamuela-Raventos RM, Joseph JA (2005) Anthocyanins in aged blueberry-fed rats are found centrally and may enhance memory. Nutr Neurosci 8:111–120
Spangler EL, Duffy K, Devan B, Guo Z, Bowker J, Shukitt-Hale B, Joseph JA, DK I (2003) Rats fed a blueberry-enriched diet exhibit greater protection against a kainate-induced learning impairment. Society for Neuroscience, Washington, DC
Joseph JA, Bielinski DF, Fisher DR (2010) Blueberry treatment antagonizes C-2 ceramide-induced stress signaling in muscarinic receptor-transfected COS-7 cells. J Agric Food Chem 58:3380–3392
Goyarzu P, Lau FC, Kaufmann J, Jennings R, Taglialatela G, Joseph J, Shukitt-Hale B, DH M (2003) age-related increase in brain NF-B is attenuated by blueberry-enriched antioxidant diet. Society for Neuroscience, Washington DC
Raymond Chuen-Chung C, Jianfei C, Man-Shan Y, Wang M (2010) Neuroprotective effects of oxyresveratrol from fruit against neurodegeneration in Alzheimer’s disease. Recent Advances on Nutrition and the Prevention of Alzheimer’s disease Kerala. Transworld Research Network, India, pp 155–168
Fortalezas S, Ll Tavares, Pimpão R, Tyagi M, Pontes V, Alves P, McDougall G, Stewart D, Ferreira R, Santos C (2010) Antioxidant properties and neuroprotective capacity of strawberry tree fruit (Arbutus unedo). Nutrients 2:214–229
Pappolla MA, Chyan YJ, Omar RA, Hsiao K, Perry G, Smith MA, Bozner P (1998) Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer’s disease—a chronic oxidative paradigm for testing antioxidant therapies in vivo. Am J Pathol 152:871–877
Heo HJ, Lee CY (2005) Strawberry and its anthocyanins reduce oxidative stress-induced apoptosis in PC12 cells. J Agric Food Chem 53:1984–1989
Kwak HM, Jeon SY, Sohng BH, Kim JG, Lee JM, Lee KB, Jeong HH, Hur JM, Kang YH, Song KS (2005) Beta-secretase (BACE1) inhibitors from pomegranate (Punica granatum) husk. Arch Pharmacal Res 28:1328–1332
Hartman RE, Shah A, Fagan AM, Schwetye KE, Parsadanian M, Schulman RN, Finn MB, Holtzman DM (2006) Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimer’s disease. Neurobiol Dis 24:506–515
Feng Y, Yang S-g, Du X-t, Zhang X, Sun X-x, Zhao M, Sun G-y, Liu R-t (2009) Ellagic acid promotes A beta 42 fibrillization and inhibits A beta 42-induced neurotoxicity. Biochem Biophys Res Commun 390:1250–1254
Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297:353–356
Bastianetto S, Zheng WH, Quirion R (2000) Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons. Br J Pharmacol 131:711–720
Wang Y-J, Thomas P, Zhong J-H, Bi F–F, Kosaraju S, Pollard A, Fenech M, Zhou X-F (2009) Consumption of grape seed extract prevents Amyloid-beta deposition and attenuates inflammation in brain of an Alzheimer’s Disease mouse. Neurotox Res 15:3–14
Wang J, Ho L, Zhao W, Ono K, Rosensweig C, Chen L, Humala N, Teplow DB, Pasinetti GM (2008) Grape-derived polyphenolics prevent A beta oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer’s disease. J Neurosci 28:6388–6392
Von Bernhardi R (2007) Glial cell dysregulation: a new perspective on Alzheimer disease. Neurotox Res 12:215–232
Kim H, Deshane J, Barnes S, Meleth S (2006) Proteomics analysis of the actions of grape seed extract in rat brain: technological and biological implications for the study of the actions of psychoactive compounds. Life Sci 78:2060–2065
Vingtdeux V, Dreses-Werringloer U, Zhao H, Davies P, Marambaud P (2008) Therapeutic potential of resveratrol in Alzheimer’s disease. Bmc Neurosci 9:5
Chandrika UG, Jansz ER, Wickramasinghe SN, Warnasuriya ND (2003) Carotenoids in yellow and red fleshed papaya (Carica papaya L.). J Sci Food Agric 83:1279–1282
Zhang J, Mori A, Chen Q, Zhao B (2006) Fermented papaya preparation attenuates beta-amyloid precursor protein: beta-amyloid-mediated copper neurotoxicity in beta-amyloid precursor protein and beta-amyloid precursor protein Swedish mutation overexpressing SH-SY5Y cells. Neuroscience 143:63–72
Remington R, Chan A, Lepore A, Kotlya E, Shea TB (2010) Apple juice improved behavioral but not cognitive symptoms in moderate-to-late stage Alzheimer’s disease in an open-label pilot study. Am J Alzheimer’s Dis Other Dementias 25:367–371
Chan A, Shea TB (2006) Supplementation with apple juice attenuates presenilin-1 overexpression during dietary and genetically-induced oxidative stress. J Alzheimer’s Dis 10:353–358
Weinreb O, Mandel S, Amit T, Youdim MBH (2004) Neurological mechanisms of green tea polyphenols in Alzheimer’s and Parkinson’s diseases. J Nutr Biochem 15:506–516
Levites Y, Amit T, Mandel S, Youdim MBH (2003) Neuroprotection and neurorescue against A beta toxicity and PKC-dependent release of non-amyloidogenic soluble precursor protein by green tea polyphenol (−)-epigallocatechin-3-gallate. Faseb J 17:952+
Guo QN, Zhao BL, Li MF, Shen SR, Xin WJ (1996) Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes. Biochim Biophys Acta Lipids Lipid Metabolism 1304:210–222
Jeong JH, Kim HJ, Lee TJ, Kim MK, Park ES, Choi BS (2004) Epigallocatechin 3-gallate attenuates neuronal damage induced by 3-hydroxykynurenine. Toxicology 195:53–60
Nanjo F, Goto K, Seto R, Suzuki M, Sakai M, Hara Y (1996) Scavenging effects of tea catechins and their derivatives on 1,1-diphenyl-2-picrylhydrazyl radical. Free Radical Biol Med 21:895–902
Braidy N, Grant R, Adams S, Guillemin GJ (2010) Neuroprotective effects of naturally occurring polyphenols on quinolinic acid-induced excitotoxicity in human neurons. FEBS J 277:368–382
Ramassamy C (2006) Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets. Eur J Pharmacol 545:51–64
Fredholm BB, Battig K, Holmen J, Nehlig A, Zvartau EE (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51:83–133
Rosso A, Mossey J, Lippa CF (2008) Caffeine: neuroprotective functions in cognition and Alzheimer’s disease. Am J Alzheimers Dis Other Dementias 23:417–422
Pereira DM, Ferreres F, Oliveira J, Valentao P, Andrade PB, Sottomayor M (2009) Targeted metabolite analysis of Catharanthus roseus and its biological potential. Food Chem Toxicol 47:1349–1354
Chauhan N, Wang KC, Wegiel J, Malik MN (2004) Walnut extract inhibits the fibrillization of amyloid beta-protein, and also defibrillizes its preformed fibrils. Curr Alzheimer Res 1:183–188
Muthaiyah B, Essa M, Chauhan V, Chauhan A (2011) Protective effects of walnut extract against amyloid beta peptide-induced cell death and oxidative stress in PC12 cells. Neurochem Res, pp 1–8
Akhondzadeh S (2007) Herbal medicine in the treatment of psychiatric and neurological disorders. In: LA L (ed) Lowcost approaches to promote physical and mental health: theory research and practice. Springer, NewYork, pp 119–138
Akhondzadeh S, Sabet MS, Harirchian MH, Togha M, Cheraghmakani H, Razeghi S, Hejazi SS, Yousefi MH, Alimardani R, Jamshidi A et al (2010) A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer’s disease. Psychopharmacology 207:637–643
Papandreou MA, Kanakis CD, Polissiou MG, Efthimiopoulos S, Cordopatis P, Margarity M, Lamari FN (2006) Inhibitory activity on amyloid-beta aggregation and antioxidant properties of Crocus sativus stigmas extract and its crocin constituents. J Agric Food Chem 54:8762–8768
Ganguli M, Chandra V, Kamboh MI, Johnston JM, Dodge HH, Thelma BK, Juyal RC, Pandav R, Belle SH, DeKosky ST (2000) Apolipoprotein E polymorphism and Alzheimer disease—the Indo-US cross-national dementia study. Arch Neurol 57:824–830
Cole GM, Teter B, Frautschy SA (2007) Neuroprotective effects of curcumin. Mol Targets Therap Uses Curcumin Health Dis 595:197–212
Ono K, Hasegawa K, Naiki H, Yamada M (2004) Curcumin has potent anti-amyloidogenic effects for Alzheimer’s beta-amyloid fibrils in vitro. J Neurosci Res 75:742–750
Yazawa K, Kihara T, Shen H, Shimmyo Y, Niidome T, Sugimoto H (2006) Distinct mechanisms underlie distinct polyphenol-induced neuroprotection. FEBS Lett 580:6623–6628
Lee SA, Hong SS, Han XH, Hwang JS, Oh GJ, Lee KS, Lee MK, Hwang BY, Ro JS (2005) Piperine from the fruits of Piper longum with inhibitory effect on monoamine oxidase and antidepressant-like activity. Chem Pharm Bull 53:832–835
Wattanathorn J, Chonpathompikunlert P, Muchimapura S, Priprem A, Tankamnerdthai O (2008) Piperine, the potential functional food for mood and cognitive disorders. Food Chem Toxicol 46:3106–3110
Selvendiran K, Singh JPV, Krishnan KB, Sakthisekaran D (2003) Cytoprotective effect of piperine against benzo[a]pyrene induced lung cancer with reference to lipid peroxidation and antioxidant system in Swiss albino mice. Fitoterapia 74:109–115
Gupta SK, Bansal P, Bhardwaj RK, Velpandian T (2000) Comparative anti-nociceptive, anti-inflammatory and toxicity profile of nimesulide vs nimesulide and piperine combination. Pharmacol Res 41:657–662
D’Hooge R, Pei YQ, Raes A, Lebrun P, vanBogaert PP, DeDeyn PP (1996) Anticonvulsant activity of piperine on seizures induced by excitatory amino acid receptor agonists. Arzneimittel-Forschung/Drug Res 46:557–560
Bai YF, Xu H (2000) Protective action of piperine against experimental gastric ulcer. Acta Pharmacol Sin 21:357–359
Chonpathompikunlert P, Wattanathorn J, Muchimapura S (2010) Piperine, the main alkaloid of Thai black pepper, protects against neurodegeneration and cognitive impairment in animal model of cognitive deficit like condition of Alzheimer’s disease. Food Chem Toxicol 48:798–802
Frydman-Marom A, Levin A, Farfara D, Benromano T, Scherzer-Attali R, Peled S, Vassar R, Segal D, Gazit E, Frenkel D, Ovadia M (2011) Orally administrated cinnamon extract reduces beta-amyloid oligomerization and corrects cognitive impairment in Alzheimer’s disease animal models. Plos One 6
Chauhan NeelimaB, Jimena S (2007) Amelioration of early cognitive deficits by aged garlic extract in Alzheimer’s transgenic mice. Phytotherap Res 21:629–640
Ursell A (2000) Natural food – Therapeutic use. In: The complete guide to healing foods. Dorling Kindersley, London, pp 120–158
Oboh G, Ademiluyi AO, Akinyemi AJ (2010) Inhibition of acetylcholinesterase activities and some pro-oxidant induced lipid peroxidation in rat brain by two varieties of ginger (Zingiber officinale). Exp Toxicol Pathol, Corrected Proof (in press)
Guillemin GJ, Meininger V, Brew BJ (2005) Implications for the kynurenine pathway and quinolinic acid in amyotrophic lateral sclerosis. Neuro-degenerative Dis 2:166–176
Smith JV, Luo Y (2004) Studies on molecular mechanisms of Ginkgo biloba extract. Appl Microbiol Biotechnol 64:465–472
Wu Y, Wu Z, Butko P, Christen Y, Lambert MP, Klein WL, Link CD, Luo Y (2006) Amyloid-beta-induced pathological behaviors are suppressed by Ginkgo biloba extract EGb 761 and ginkgolides in transgenic Caenorhabditis elegans. J Neurosci 26:13102–13113
Ahlemeyer B, Krieglstein J (2003) Neuroprotective effects of Ginkgo biloba extract. Cell Mol Life Sci 60:1779–1792
Sasaki K, Hatta S, Wada K, Ueda N, Yoshimura T, Endo T, Sakata M, Tanaka T, Haga M (2002) Effects of extract of Ginkgo biloba leaves and its constituents on carcinogen-metabolizing enzyme activities and glutathione levels in mouse liver. Life Sci 70:1657–1667
Shi C, Zhao L, Zhu B, Li Q, Yew DT, Yao Z, Xu J (2009) Protective effects of Ginkgo biloba extract (EGb761) and its constituents quercetin and ginkgolide B against beta-amyloid peptide-induced toxicity in SH-SY5Y cells. Chem Biol Interact 181:115–123
Maclennan KM, Darlington CL, Smith PE (2002) The CNS effects of Ginkgo biloba extracts and ginkgolide B. Prog Neurobiol 67:235–257
Hynes N, Bishai I, Lees J, Coceani F (1991) Leucotrenes in Brain—natural occurence and induced changes. Brain Res 553:4–13
Colciaghi F, Borroni B, Zimmermann M, Bellone C, Longhi A, Padovani A, Cattabeni F, Christen Y, Di Luca M (2004) Amyloid precursor protein metabolism is regulated toward alpha-secretase pathway by Ginkgo biloba extracts. Neurobiol Dis 16:454–460
Yao ZX, Han ZQ, Drieu K, Papadopoulos V (2004) Ginkgo biloba extract (Egb 761) inhibits beta-amyloid production by lowering free cholesterol levels. J Nutr Biochem 15:749–756
Tsuzuki K, Fukatsu R, Yamaguchi H, Tateno M, Imai K, Fujii N, Yamauchi T (2000) Transthyretin binds amyloid beta peptides, A beta 1-42 and A beta 1-40 to form complex in the autopsied human kidney—possible role of transthyretin for A beta sequestration. Neurosci Lett 281:171–174
Watanabe CMH, Wolffram S, Ader P, Rimbach G, Packer L, Maguire JJ, Schultz PG, Gohil K (2001) The in vivo neuromodulatory effects of the herbal medicine ginkgo biloba. Proc Natl Acad Sci USA 98:6577–6580
Shi C, Liu J, Wu F, Yew DT (2010) Ginkgo biloba extract in Alzheimer’s disease: from action mechanisms to medical practice. Int J Mol Sci 11:107–123
Kuboyama T, Tohda C, Komatsu K (2006) Withanoside IV and its active metabolite, sominone, attenuate A beta(25-35)-induced neurodegeneration. Eur J Neurosci 23:1417–1426
Kim JK, Bae H, Kim M-J, Choi SJ, Cho HY, Hwang H-J, Kim YJ, Lim ST, Kim EK, Kim HK et al (2009) Inhibitory effect of Poncirus Trifoliate on acetylcholinesterase and attenuating activity against trimethyltin-induced learning and memory impairment. Biosci Biotechnol Biochem 73:1105–1112
Akhondzadeh S, Noroozian M, Mohammadi M, Ohadinia S, Jamshidi AH, Khani M (2003) Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer’s disease: a double blind, randomized and placebo-controlled trial. J Clin Pharm Ther 28:53–59
Kim SR, Lee KY, Koo KA, Sung SH, Lee NG, Kim J, Kim YC (2002) Four new neuroprotective iridoid glycosides from Scrophularia buergeriana roots. J Nat Prod 65:1696–1699
Jeong EJ, Ma CJ, Lee KY, Kim SH, Sung SH, Kim YC (2009) KD-501, a standardized extract of Scrophularia Buergeriana has both cognitive-enhancing and antioxidant activities in mice given scopolamine. J Ethnopharmacol 121:98–105
Kim Y, Park EJ, Kim J, Kim YB, Kim SR, Kim YC (2001) Neuroprotective constituents from Hedyotis diffusa. J Nat Prod 64:75–78
Zhao Q, Tang XC (2002) Effects of huperzine A on acetylcholinesterase isoforms in vitro: comparison with tacrine, donepezil, rivastigmine and physostigmine. Eur J Pharmacol 455:101–107
Xiao XQ, Yang JW, Tang XC (1999) Huperzine A protects rat pheochromocytoma cells against hydrogen peroxide-induced injury. Neurosci Lett 275:73–76
Xiao XQ, Wang R, Han YF, Tang XC (2000) Protective effects of huperzine A on beta-amyloid(25-35) induced oxidative injury in rat pheochromocytoma cells. Neurosci Lett 286:155–158
Xiao XQ, Wang R, Tang XC (2000) Huperzine A and tacrine attenuate beta-amyloid peptide-induced oxidative injury. J Neurosci Res 61:564–569
Zhang HY, Yan H, Tang XC (2004) Huperzine A enhances the level of secretory amyloid precursor protein and protein kinase C-alpha in intracerebroventricular beta-amyloid-(1-40) infused rats and human embryonic kidney 293 Swedish mutant cells. Neurosci Lett 360:21–24
Wang R, Tang XC (2005) Neuroprotective effects of huperzine A—a natural cholinesterase inhibitor for the treatment of Alzheimer’s disease. Neurosignals 14:71–82
Goswami S, Saoji A, Kumar N, Thawani V, Tiwari MT (2011) Effect of Bacopa monnieri on cognitive functions in Alzheimer’s disease patients. Int J Collaborat Res Int Med Public Health 3:285–293
Fujiwara H, Tabuchi M, Yamaguchi T, Iwasaki K, Furukawa K, Sekiguchi K, Ikarashi Y, Kudo Y, Higuchi M, Saido TC et al (2009) A traditional medicinal herb Paeonia suffruticosa and its active constituent 1,2,3,4,6-penta-O-galloyl-beta-d-glucopyranose have potent anti-aggregation effects on Alzheimer’s amyloid beta proteins in vitro and in vivo. J Neurochem 109:1648–1657
Fujiwara H, Iwasaki K, Furukawa K, Seki T, He M, Maruyama M, Tomita N, Kudo Y, Higuchi M, Saido TC et al (2006) Uncaria rhynchophylla, a Chinese medicinal herb, has potent antiaggregation effects on Alzheimer’s beta-amyloid proteins. J Neurosci Res 84:427–433
Ganguly R, Hazra R, Ray K, Guha D (2005) Effect of Moringa Oleifera in experimental model of Alzheimer’s disease: role of antioxidant. Ann Neurosci 12
Tamaki Y, Tabuchi T, Takahashi T, Kosaka K, Satoh T (2010) Activated glutathione metabolism participates in protective effects of Carnosic acid against oxidative stress in neuronal HT22 cells. Planta Med 76:683–688
Wijeratne SSK, Cuppett SL (2007) Potential of rosemary (Rosemarinus officinalis L.) diterpenes in preventing lipid hydroperoxide-mediated oxidative stress in Caco-2 cells. J Agric Food Chem 55:1193–1199
Marco L, MdC Carreiras (2006) Galanthamine, a natural product for the treatment of Alzheimers disease. Rec Pat CNS Drug Discov 1:105–111
Lee S-T, Chu K, Sim J-Y, Heo J-H, Kim M (2008) Ponax Ginseng enhances cognitive performance in Alzheimer disease. Alzheimer Dis Assoc Disord 22:222–226
Lee YK, Yuk DY, Kim TI, Kim YH, Kim KT, Kim KH, Lee BJ, Nam S-Y, Hong JT (2009) Protective effect of the ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on scopolamine-induced memory impairment and the inhibition of acetylcholinesterase activity. J Nat Med 63:274–282
Ashwlayan VD, Singh R (2011) Reversal effect of Phyllanthus Emblica (Euphorbiaceae) Rasayana on memory deficits in mice. Int J Appl Pharm 3:10–15
Panjwani D, Mishra B, Banji D (2010) Time dependent antioxidant activity of fresh juice of leaves of Coriandrum Sativum. Int J Pharm Sci Drug Res 2:63–66
Mani V, Parle M, Ramasamy K, Abdul Majeed AB (2010) Reversal of memory deficits by Coriandrum sativum leaves in mice. J Sci Food Agric 91:186–192
Brunner E, Ehrlich H, Schupp P, Hedrich R, Hunoldt S, Kammer M, Machill S, Paasch S, Bazhenov VV, Kurek DV et al (2009) Chitin-based scaffolds are an integral part of the skeleton of the marine demosponge Ianthella basta. J Struct Biol 168:539–547
Gervais F, Paquette J, Morissette C, Krzywkowski P, Yu M, Azzi M, Lacombe D, Kong X, Aman A, Laurin J et al (2007) Targeting soluble A beta peptide with Tramiprosate for the treatment of brain amyloidosis. Neurobiol Aging 28:537–547